Back to News
Market Impact: 0.3
TME Pharma signe un accord de négociation exclusif et contraignant avec la société japonaise TMS Co., Ltd.
Source: globenewswire.com
Healthcare & BiotechM&A & RestructuringCompany Fundamentals
TME Pharma signed a binding exclusivity agreement with Japan’s TMS Co. and will receive €150,000 for six months of exclusive negotiations. The parties will negotiate a definitive agreement covering worldwide rights to NOX-A12; no final licensing deal was announced.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
ALTME0.50
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Warren urges DOJ criminal probe of Bank of America over anti-money-laundering violations
- PC chip plunge wipes out a quarter of Intel’s value